Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for postoperative analgesia and immune function in thoracoscopic surgery for tuberculosis
ChiCTR2500115473Phase 4Not yet recruiting
- Sponsor
- Hebei Province Chest Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain (2 arms), sponsored by Hebei Province Chest Hospital. Primary endpoint: Visual Analogue Scale (VAS) pain score. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500115473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115473.